Stereotactic body radiotherapy for lung oligometastases: Literature review according to PICO criteria.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Exhaustive criteria and definitive data to identify the ideal lung oligometastatic patient as a candidate for stereotactic body radiotherapy (SBRT) are lacking. Three distinct cohorts of oligometastatic patients could be distinguished: (1) patients with upfront diagnosis of oligometastases (synchronous or metachronous); (2) patients with oligorecurrent disease in terms of relapsed oligometastatic phase; (3) oligoprogressive patients after cytoreductive treatment. The aim of the present review is to analyze available data concerning the efficacy/safety of SBRT for oligometastatic/oligoprogressive/oligorecurrent lung metastases.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Tumori

Title: Tumori

Publisher: SAGE Publications

ISSN (Electronic): 2038-2529

ISSN (Print): 0300-8916

Publication date (Electronic): Jun 2018

Volume: 104

Issue: 3

Affiliations

[1 ] 1 Radiation Oncology, Sacro Cuore Don Calabria Hospital, Negrar-Verona, Italy.

[2 ] 2 University of Brescia, Brescia, Italy.

[3 ] 3 Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland.

Article

DOI: 10.1177/0300891618766820

PubMed ID: 29714665

SO-VID: 7187dd77-d0a2-4bf9-930e-e99d96f14193

History

Keywords: PICO criteria,SBRT,lung oligometastases,review

Data availability:

Keywords: PICO criteria, SBRT, lung oligometastases, review

Comments

Comment on this article

scite_

Cited by 4

See all cited by